AIM
CATX icon

Aigen Investment Management’s Perspective Therapeutics CATX Stock Holding History

Aigen Investment Management’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.9K Buy
+20,509
New +$77.5K 0.02% 492
2026
Q1 		– Sell
-10,173
Closed -$28K – 549
2025
Q4 		$28K Buy
+10,173
New +$29K 0.01% 546
2025
Q1 		– Sell
-10,522
Closed -$33.6K – 783
2024
Q4 		$33.6K Buy
+10,522
New +$85.9K 0.01% 697

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Aigen Investment Management's CATX Position: Q2 2026 in Review

Aigen Investment Management opened a new position in Perspective Therapeutics (CATX) in Q2 2026: 20,509 shares worth $69.9K. The stake represents 0.02% of the portfolio and ranks #492 among its holdings. This is a return to the name: Aigen Investment Management previously reported a position in CATX as recently as Q4 2025.

Aigen Investment Management first reported a position in CATX in Q4 2024 and has held it in 3 quarters since. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Aigen Investment Management held 20,509 shares of Perspective Therapeutics worth $69.9K as of Q2 2026.
  • Perspective Therapeutics was a new Aigen Investment Management position in Q2 2026.
  • Perspective Therapeutics made up 0.02% of Aigen Investment Management's portfolio in Q2 2026, its #492 holding.
  • Aigen Investment Management first reported a position in Perspective Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.